The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...

Going for a regular eye check-up is about more than assessing your ability to see. Your eyes can be a window to early ...

Secondary techniques are needed to address macular holes in patients with myopia, according to a speaker at OSN New York ...

Discover the causes of eye floaters, why they occur, when they signify serious eye conditions, and expert advice on what to do if you notice changes in your vision.

In China, doctors reported a case of short-term vision loss in a 24-year-old resident of Zhangjiajie. According to doctors, the cause was changes in the fundus, characteristic of an extremely high ...

Dr. Clayton Kirk, retina specialist with Eye Surgeons Associates, explains the warning signs of retinal tears and retinal ...

First and only FDA-approved treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period Monthly dosing option in all approved indications provides greater dosing ...

EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics ...

The FDA has approved Eylea HD (aflibercept) 8 mg to treat patients with macular edema following retinal vein occlusion (RVO) with dosing of up to every 8 weeks after an initial monthly dosing period.

Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced data from a post hoc analysis of the GALE extension study ...

Age-related macular degeneration (AMD) is a leading cause of blindness in the older population. Geographic atrophy is an advanced stage of dry AMD, characterized by irreversible vision loss due to the ...